Results 11 to 20 of about 23,486 (164)
Platelets, 2020 HIT, a prothrombotic disorder caused by heparin-dependent antibodies, is often treated with fondaparinux, usually with good outcomes. A 70-year-old female developed severe HIT (platelet count, 25 × 109/L) post-glioblastoma resection during heparin ...
Farheen Manji +3 more
doaj +1 more source
Frontiers in Endocrinology, 2021 BackgroundTo compare the clinical efficacy of fondaparinux and LMWH and provide clinical evidence for the effectiveness of fondaparinux in the treatment of recurrent spontaneous abortion caused by PTS.MethodsA retrospective analysis was conducted for 120
Long Zhao +5 more
doaj +1 more source
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 2019 Pendahuluan: Fondaparinux 2,5 mg sebagai terapi antikoagulan pada pasien Sindroma Koroner Akut (SKA) di RSUD Dr. Soetomo Surabaya diberikan selama 5 hari, sedangkan pustaka menyebutkan bahwa fondaparinux diberikan selama 3 - 7 hari.
Arina Dery Puspitasari +2 more
doaj +1 more source
Fondaparinux-associated Thrombocytopenia
Pakistan Journal of Medical Sciences, 2021 Heparin-induced thrombocytopenia (HIT) is an immune-mediated condition causing thrombocytopenia and paradoxical thrombosis after exposure to heparin or low-molecular-weight heparin. It has been rarely reported by Fondaparinux, an artificial pentasaccharide similar to heparin. This manuscript presents a case of HIT associated with fondaparinux use. doi:
Malik, Jahanzeb +2 more
openaire +3 more sources
Global Spine Journal, 2020 Study Design: Retrospective cohort study. Objective: To assess the impact of fondaparinux on venous thromboembolism (VTE) following elective lumbar spine surgery in high-risk patients. Methods: Matched patient cohorts who did or did not receive inpatient
Mitchell S. Fourman MD, MPhil +8 more
doaj +1 more source
Clinical and Applied Thrombosis/Hemostasis, 2021 We analyzed data for women who received fondaparinux for ≥7 days during pregnancy. The study retrospectively included women who received fondaparinux pre-, peri- and/or postpartum for ≥7 days for prophylaxis/venous thromboembolism (VTE) treatment at ...
Carl-Erik Dempfle MD +10 more
doaj +1 more source
ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
Рациональная фармакотерапия в кардиологии, 2016 Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Author’s brief experience of fondaparinux clinical implementation is presented.
I. A. Latfullin, A. A. Podolskaya
doaj +3 more sources
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O uso combinado de agentes antitrombínicos, antiplaquetários e estratégias invasivas na síndrome coronariana aguda sem supradesnivelamento do ST (SCAsSST) reduz eventos cardiovasculares. O fondaparinux demonstrou equivalência à enoxaparina na
Camila Pepe +3 more
doaj +1 more source
Can this be considered a Fondaparinux-induced Thrombocytopenia?
European Journal of Case Reports in Internal Medicine, 2014 We present a case of an old woman with previously documented heparin-induced thrombocytopenia (HIT), treated with fondaparinux, who presented with thrombocytopenia and venous thrombosis after exposure to a preventive dose of fondaparinux during ...
Barbara Mariotti +2 more
doaj +1 more source